News - Pharmaceutical, Asia-Pacific, Mergers & Acquisitions

1 to 25 of 54 results

Lansen Pharma acquires China rights to Novartis’ Sicorten Plus

Lansen Pharma acquires China rights to Novartis’ Sicorten Plus

31-03-2014

Hong Kong-listed Lansen Pharmaceutical has acquired the pharmaceutical product, marketed and sold in…

Asia-PacificChinaDermatologicalsLansen PharmaceuticalMergers & AcquisitionsNovartisPharmaceuticalSicorten

Amount of foreign direct investment proves India’s attraction to Big Pharma despite protestations on IP

Amount of foreign direct investment proves India’s attraction to Big Pharma despite protestations on IP

31-03-2014

Multinational drugmakers might be crying themselves hoarse that India does not protect innovation - that…

Asia-PacificBristol-Myers SquibbFinancialGlaxoSmithKlineIndiaMerck & CoMergers & AcquisitionsMylan LaboratoriesPatentsPharmaceuticalSanofi

GSK acquires remaining 30% of its Indonesian Consumer Healthcare business

GSK acquires remaining 30% of its Indonesian Consumer Healthcare business

28-03-2014

US pharma giant GlaxoSmithKline has acquired full ownership of its Indonesian Consumer Healthcare business…

Asia-PacificGlaxoSmithKlineIndonesiaMergers & AcquisitionsPharmaceuticalProduction

AstraZeneca acquires full control of Japanese subsidiary

AstraZeneca acquires full control of Japanese subsidiary

26-03-2014

Anglo-Swedish drug major AstraZeneca today announced the completion of the purchase of Sumitomo Chemical’s…

Asia-PacificAstraZenecaJapanMergers & AcquisitionsPharmaceutical

GSK increases stake in Indian Pharma subsidiary to 75%

GSK increases stake in Indian Pharma subsidiary to 75%

10-03-2014

UK pharma giant GlaxoSmithKline says that, following the voluntary open offer undertaken by its Indian…

Asia-PacificGlaxoSmithKlineIndiaMergers & AcquisitionsPharmaceutical

Indian drugmakers readying for next “Patent cliff”

24-02-2014

The strategic drug reviews, as well as mergers and acquisitions – such as Actavis buying out Forest…

Asia-PacificGenericsIndiaMergers & AcquisitionsPatentsPharmaceuticalRegulation

Growing Indian pharma market provides incentives for foreign acquisitions

20-01-2014

A recent IMS Institute for Healthcare Informatics global study has revealed that greater access to medicines…

Asia-PacificIndiaMarkets & MarketingMergers & AcquisitionsPharmaceutical

Indian government proceeds with FDI policy, despite warnings

Indian government proceeds with FDI policy, despite warnings

20-01-2014

Overlooking concerns about the scarcity of generic drugs in the domestic market given the spate of multinationals…

Asia-PacificIndiaMergers & AcquisitionsPharmaceuticalPolitics

GlaxoSmithKline to lift stake in Indian subsidiary to 75%

GlaxoSmithKline to lift stake in Indian subsidiary to 75%

16-12-2013

UK pharma major GlaxoSmithKline said this morning that it plans to increase its stake in its publicly-listed…

Asia-PacificGlaxoSmithKlineIndiaMergers & AcquisitionsPharmaceutical

Torrent to acquire Indian branded formulations from Elder

13-12-2013

Torrent Pharmaceuticals saw its shares rise 7% to 349 rupees after it said it is acquiring the branded…

Asia-PacificElder PharmaceuticalsIndiaMergers & AcquisitionsNeurologicalPharmaceuticalTorrent PharmaceuticalsWomen's Health

Report 1: Growth strategies in Japan’s pharma market, by P Reed Maurer

Report 1: Growth strategies in Japan’s pharma market, by P Reed Maurer

02-12-2013

P Reed Maurer, long-time Japanese pharma industry watcher and president of International Alliances Limited,…

Asia-PacificMergers & AcquisitionsPharmaceutical

Imugene to acquire Biolife Sciences

24-10-2013

Australian drug development and pharmaceutical company Imugene says it has executed a sale and purchase…

Asia-PacificMergers & AcquisitionsOncologyPharmaceutical

Alliance Boots and Walgreens expansion into China an "obvious next step," says EIU analyst

10-06-2013

Following the news that Alliance Boots and the USA's Walgreen, which initially took a 45% stake in the…

Alliance BootsAsia-PacificMarkets & MarketingMergers & AcquisitionsPharmaceuticalWalgreens

Vectura sets up JV, Kinnovata, for new respiratory business in China

13-05-2013

UK-based developer of inhaled therapies Vectura (LSE: VEC) saw its shares rise 4.8% to 96.93 pence in…

Asia-PacificMergers & AcquisitionsPharmaceuticalProductionRespiratory and PulmonaryTianjin KingYorkTianjin Kinnovata PharmaVecturaZendex Bio Strategy

Alliance Boots to build up interest in China

07-05-2013

According to the Financial Times, Stefano Pessina, executive chairman of Alliance Boots, is looking to…

Alliance BootsAsia-PacificMarkets & MarketingMergers & AcquisitionsPharmaceuticalWalgreens

Sagent Pharma to buy remaining 50% stake in Chinese JV for $25 million

06-05-2013

US specialty pharmaceutical company Sagent Pharmaceuticals (Nasdaq: SGNT) has entered into an agreement…

Asia-PacificGenericsKanghong Sagent (Chengdu) PharmaceuticalMergers & AcquisitionsPharmaceuticalProductionSagent Pharmaceuticals

Analysis of China government incentives for pharma

27-03-2013

China remains an attractive target for pharmaceutical research and manufacturing, and major players from…

Asia-PacificLicensingMarkets & MarketingMergers & AcquisitionsPatentsPharmaceutical

GlaxoSmithKline and Biological E set up JV to develop combination vaccine

29-01-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and Indian vaccines company Biological E have entered into…

Asia-PacificBiological E LtdGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalResearchVaccines

Aggressive strategies confirm Big Pharma's Indian interest

27-01-2013

The increasing number of consolidations and in-licensing agreements between multinational corporations…

Asia-PacificLicensingMarkets & MarketingMergers & AcquisitionsPharmaceutical

Japan Pharma: Expectations for 2013, by P Reed Maurer

03-01-2013

The biggest non-event in the Japan health care market during 2013 will be no reimbursement price reductions,…

Asia-PacificGenericsLicensingMergers & AcquisitionsPharmaceuticalPricingResearch

Canada's Pharmascience sets up JV with Korea Kolmar; buys Rivex

03-01-2013

Privately-held Canadian drugmaker Pharmascience and Korea Kolmar Holdings, based in Seoul, South Korea,…

Asia-PacificBiotechnologyGenericsHelix BioPharmaKorea KolmarMergers & AcquisitionsNeurologicalNorth AmericaPharmaceuticalPharmascienceRivex Pharma

WuXi PharmaTech sets up clinical trials JV with PRA

27-12-2012

Chinese contract research organization WuXi PharmaTech (NYSE: WX) and PRA, a global clinical CRO, have…

Asia-PacificMergers & AcquisitionsPharmaceuticalResearchWuXi PharmaTech

No "Japan pharma for sale signs," by P Reed Maurer

18-12-2012

Want to acquire a Japanese pharmaceutical company? Join the back of a long line of companies with the…

Asia-PacificGenericsMergers & AcquisitionsPharmaceutical

News briefs: US Crestor patent upheld; Pfizer animal health plans; Teva South Korea JV

17-12-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZ) said on Friday that the US Court of Appeals for the Federal…

Asia-PacificAstraZenecaCrestorGenericsHandok PharmaceuticalsLegalMergers & AcquisitionsNorth AmericaPatentsPfizerPharmaceuticalTeva Pharmaceutical IndustriesZoetis

1 to 25 of 54 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top